NGS Screening Protocol to Detect Mutation of KEAP1 or NRF2/NFE2L2 Genes for the KEAPSAKE (CX-839-014) Trial
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Emil Kuriakose, MD
Calithera Biosciences, Inc
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
63 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Southern Cancer Center
Daphne, Alabama, United States
- Southern Cancer Center - 3 Mobile Infirmary Circle
Mobile, Alabama, United States
- Southern Cancer Center - Dauphin St
Mobile, Alabama, United States
- Southern Cancer Center - Providence Hospital
Mobile, Alabama, United States
- Arizona Oncology Associates - Glendale
Glendale, Arizona, United States
- Arizona Oncology Associates - E. Highland Ave.
Phoenix, Arizona, United States
- Arizona Oncology Associates - N. 27th Ave.
Phoenix, Arizona, United States
- Arizona Oncology Associates
Scottsdale, Arizona, United States
- Arizona Oncology Associates - Tempe
Tempe, Arizona, United States
- Rocky Mountain Cancer Centers - Aurora
Aurora, Colorado, United States
- Rocky Mountain Cancer Centers - Boulder
Boulder, Colorado, United States
- Rocky Mountain Cancer Centers - Centennial
Centennial, Colorado, United States
- Rocky Mountain Cancer Centers - Colorado Springs
Colorado Springs, Colorado, United States
- Rocky Mountain Cancer Centers - E. Hale Parkway
Denver, Colorado, United States
- Rocky Mountain Cancer Centers - Williams Street
Denver, Colorado, United States
- Rocky Mountain Cancer Centers - Englewood
Englewood, Colorado, United States
- Rocky Mountain Cancer Centers - Lakewood
Lakewood, Colorado, United States
- Rocky Mountain Cancer Centers - Littleton
Littleton, Colorado, United States
- Rocky Mountain Cancer Centers - Lone Tree
Lone Tree, Colorado, United States
- Rocky Mountain Cancer Centers - Longmont
Longmont, Colorado, United States
- Rocky Mountain Cancer Centers - Pueblo
Pueblo, Colorado, United States
- Rocky Mountain Cancer Centers - Thornton
Thornton, Colorado, United States
- Medical Oncology Hematology Consultants
Newark, Delaware, United States
- Woodlands Medical Specialists
Pensacola, Florida, United States
- Maryland Oncology Hematology - Bethesda
Bethesda, Maryland, United States
- Maryland Oncology Hematology - Brandywine
Brandywine, Maryland, United States
- Maryland Oncology Hematology - Clinton
Clinton, Maryland, United States
- Maryland Oncology Hematology
Columbia, Maryland, United States
- Maryland Hematology Oncology - Frederick
Frederick, Maryland, United States
- Maryland Oncology Hematology - Lanham
Lanham, Maryland, United States
- Maryland Hematology Oncology - Rockville
Rockville, Maryland, United States
- Maryland Hematology Oncology - Silver Spring
Silver Spring, Maryland, United States
- Oncology Hematology Care - Ivy Gateway
Cincinnati, Ohio, United States
- Oncology Hematology Care - Malsbary Rd
Cincinnati, Ohio, United States
- Oncology Hematology Care - Mercy Health Blvd
Cincinnati, Ohio, United States
- Oncology Hematology Care - Fairfield
Fairfield, Ohio, United States
- Northwest Cancer Specialists - N. Broadway
Portland, Oregon, United States
- Northwest Cancer Specialists - Ne Hoyt St
Portland, Oregon, United States
- Northwest Cancer Specialists
Tigard, Oregon, United States
- Consultants in Medical Oncology and Hematology
Broomall, Pennsylvania, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 19 Jan 2021
- Primary completion
- 5 Nov 2021
- Completion
- 9 Feb 2022
- Last update posted
- 13 Mar 2023
- Registered enrollment
- 20
- Registry id
- NCT04698681
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.